Direkt zur Navigation Direkt zum Inhalt

Abstracts 2010 (12th Symposium)

Responsible for content:
Scientific Advisory Board Swiss MS-Society

Chairmen:
Prof. Ludwig Kappos, Basel
PD Myriam Schluep, Lausanne

Does Current Neuropathological Evidance Help in Defining Therapeutic Targets?(97.38 kb)
Prof. Wolfgang Brück, Göttingen (D)

Update on MS Immunology(165.11 kb)
Prof. Burkhard Becher, Zurich

Current and Emerging Treatment Options in MS: Achieved and Expected Benefits(135.49 kb)
Prof. Ludwig Kappos, Basel

Short and Long Term Risks of Immunointervention - The Perspective of the Rheumatologist(162.32 kb)
Prof. Alan Tyndall, Basel

Infections as Complications of Immunointervention –Diagnosis, Prevention and Treatment(179.89 kb)
Prof. Renaud Du Pasquier, Lausanne

Psychiatric (Co)-morbidity in MS – Diagnostic and Therapeutic Challenges(137.2 kb)
PD Dr. Pasquale Calabrese, Basel

Workshop A: Natalizumab in Daily Practice – Risks and Benefits(185.71 kb)
PD Dr. Myriam Schluep, Lausanne Dr. Jens Kuhle, Basel

Workshop B: Immunological and Molecular Investigations in MS - what should Neurologist know?(173.58 kb)
PD Dr. Patrice Lalive, Geneva Prof. Raija Lindberg, Basel

Workshop C: Understanding new MRI Developments - Implications for Clinical Practice(204.86 kb)
Prof. Ernst-Wilhelm Radü, Basel Prof. Achim Gass, Basel

Workshop D: Treatment failure, what to do?(96.8 kb)
PD Dr. Adam Czaplinski, Zurich Dr. Yvonne Naegelin, Basel

Workshop E: Neuropsychological Assessment and Treatment in MS(97.26 kb)
PD Dr. Iris-Katharina Penner, Basel Dr. Serafin Beer, Valens

Workshop F: RIS, CIS and Early MS – Diagnostic and Therapeutic Challanges(135.89 kb)
Dr. Claudio Gobbi, Lugano Dr. Carmen Lienert, Basel